Medical Blog About Treatment Abroad

Breast cancer (BCa) affects more than 2 million women each year, and approximately 10 percent of the cases are diagnosed with stage 4 and metastases. German hospitals are the best providers of cancer treatment, as the most effective ones due to the combination of innovative technology with holistic treatment...

With diabetes affecting 589 million adults worldwide – representing 1 in 9 adults – and projections showing this could reach 853 million by 2050, innovative treatment approaches are increasingly vital. Stem cell treatment for diabetes is a method of treating diabetes mellitus by injecting stem cells, own or donor ones.

Colorectal cancer (CRC) is a major public health concern in Germany and is among the most frequently diagnosed cancers. In 2022, approximately 24,650 women and 29,960 men were newly diagnosed with CRC. Most cases arise in the colon, with relatively few in the rectum, and incidence rates increase sharply after the age of...

Esophageal cancer is one of the twenty most widespread cancer types. The disease can develop at any age, but most often it is diagnosed over the age of 60, when treatment options are already somewhat limited by the patient's chronic conditions. Patients who undergo treatment in Germany have a chance to significantly...

Germany stands at forefront of stage 4 lung cancer treatment — known for precision-driven protocols and infrastructure that supports them. Lung cancer remains most commonly diagnosed cancer worldwide: approximately 2.2 million new cases and 1.8 million deaths recorded in 2020. Despite those numbers...

In 2020, 1.4 million men were newly diagnosed with prostate cancer. Northern and Western Europe, the Caribbean, Australia/ New Zealand, North and South America, and Southern Africa have the highest age-standardized incidence rates. This is why new, innovative approaches are required, which could treat prostate...

Cancer remains too common across Europe. In 2022 alone, there were approximately 4.47 million new cancer diagnoses – that's nearly one in four people up to age 75 developing cancer in their lifetime. Oncological diseases are the second leading cause of death in the world after cardiovascular disease, and their prevalence continues...

Glioblastoma is a relatively rare and extremely aggressive brain tumor. An extensive epidemiological survey has recorded that the mean incidence of glioblastoma is about 3.19 cases per 100,000 people per year. Its aggressiveness is due to the rate at which glioblastoma cells multiply and spread to normal brain tissue, thus making the disease...